STOCK TITAN

Cooper Companies (NYSE: COO) director exercises 7,064 options for shares

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Cooper Companies director Colleen Jay reported exercising stock options and increasing her direct shareholdings. On 01/12/2026, she exercised 7,064 stock options with an exercise price of $39.4 per share, converting them into the same number of shares of Common Stock.

Following this transaction, she directly held 36,585 shares of Common Stock. The exercised stock option award was fully used, leaving 0 derivative securities of that option grant outstanding.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jay Colleen

(Last) (First) (Middle)
C/O THE COOPER COMPANIES, INC.
6101 BOLLINGER CANYON ROAD, SUITE 500

(Street)
SAN RAMON CA 94583

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COOPER COMPANIES, INC. [ COO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/12/2026 M 7,064 A $39.4 36,585 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $39.4 01/12/2026 M 7,064 04/01/2017 04/01/2026 Common Stock 7,064 $0.00 0.00 D
Explanation of Responses:
Remarks:
Colleen Jay by Greta Kolcon, as Attorney-in-Fact 01/14/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cooper Companies (COO) report?

A director, Colleen Jay, exercised 7,064 stock options on 01/12/2026, acquiring the same number of Common Stock shares.

At what price were the Cooper Companies (COO) options exercised?

The stock options were exercised at an exercise price of $39.4 per share, as shown in the derivative securities table.

How many Cooper Companies (COO) shares does the director own after the transaction?

After the option exercise, the director beneficially owned 36,585 shares of Common Stock, held with direct ownership.

What happened to the stock options after the Cooper Companies (COO) exercise?

The 7,064 stock options were exercised under transaction code M, and the number of those derivative securities beneficially owned became 0.

What is the relationship of the reporting person to Cooper Companies (COO)?

The reporting person, Colleen Jay, is listed as a Director of Cooper Companies, Inc., and not as a 10% owner or officer.

Is the Cooper Companies (COO) Form 4 filed for one or multiple insiders?

The Form 4 is indicated as Form filed by One Reporting Person, covering only director Colleen Jay.
Cooper

NASDAQ:COO

COO Rankings

COO Latest News

COO Latest SEC Filings

COO Stock Data

16.26B
178.32M
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
SAN RAMON